The study focused on 6,542 childhood cancer survivors over 18 who were diagnosed with cancer between 1970 and 1986 and 368 of their siblings as a control group. The study found that 589 survivors, or 9 percent, reported significant functional impairment and clinical distress as well as symptoms...
Background
Recent advances in breast cancer, colon cancer, and melanoma treatment show the importance of detailed molecular analysis of tumor samples to find new therapeutic targets. By comparison, progress in the molecular characterizations of childhood brain tumors is much slower. The majority...
Dr. Curran is the Deputy Scientific Director at Children's Hospital of Philadelphia, Professor of Pathology and Laboratory Medicine at the University of Pennsylvania, an Investigator of the Abramson Family Cancer Research Institute, and an Investigator of the Research Institute of the Children's...
Opinions about the Children’s Brain Tumor Tissue Consortium from three leading non-affiliated researchers across the United States.
I think this is an excellent proposal...very thorough, innovative, very detailed and crucial to the understanding of pediatric brain tumors, led by a...
